Ankyloblepharon
|
0.200 |
GeneticVariation
|
disease |
BEFREE |
Novel variant in the TP63 gene associated to ankyloblepharon-ectodermal dysplasia-cleft lip/palate (AEC) syndrome.
|
27485918 |
2017 |
Ankyloblepharon
|
0.200 |
GeneticVariation
|
disease |
BEFREE |
The third hallmark of the EEC syndrome is orofacial clefting, in particular lip and palate. p63 mutations also cause the other five inherited syndromes: symptoms are overlapping, but each of these diseases has its own characteristic phenotypic features: for instance AEC syndrome (ankyloblepharon-ectodermal defects-cleft lip/palate) has as distinctive feature ankyloblepharon, while mammary glands and nipples hypoplasia are frequent findings in LMS syndrome and in ADULT syndrome (acro-dermato-ungual-lacrimal-tooth syndrome).
|
23407076 |
2013 |
Ankyloblepharon
|
0.200 |
GeneticVariation
|
disease |
BEFREE |
Unlike some of the other TP63-associated ectodermal dysplasias, ADULT syndrome lacks clefting and ankyloblepharon.
|
22607287 |
2012 |
Ankyloblepharon
|
0.200 |
GeneticVariation
|
disease |
BEFREE |
The basis for impaired differentiation in TP63 mutant ankyloblepharon-ectodermal dysplasia-clefting (AEC) syndrome is unknown.
|
22922031 |
2012 |
Ankyloblepharon
|
0.200 |
GeneticVariation
|
disease |
BEFREE |
AEC (ankyloblepharon-ectodermal defects-clefting) syndrome is an autosomal dominant ectodermal dysplasia disorder caused by mutations in the transcription factor p63.
|
22329826 |
2012 |
Ankyloblepharon
|
0.200 |
GeneticVariation
|
disease |
BEFREE |
In humans p63 mutations are associated with several distinct developmental syndromes. p63 sterile-α-motif domain, AEC (ankyloblepharon-ectodermal dysplasia-clefting)-associated mutations are associated with a high prevalence of orofacial clefting disorders, which are less common in EEC (ectrodactyly-ectodermal dysplasia-clefting) patients with DNA binding domain p63 mutations.
|
21965674 |
2011 |
Ankyloblepharon
|
0.200 |
GeneticVariation
|
disease |
BEFREE |
Mutations in sterile alpha motif (SAM) domain of TP63 have been reported to be associated with ankyloblepharon-ectodermal dysplasia-cleft lip/palate syndrome and Rapp-Hodgkin syndrome.
|
21567929 |
2011 |
Ankyloblepharon
|
0.200 |
GeneticVariation
|
disease |
BEFREE |
Ankyloblepharon-ectodermal defect-cleft lip and/or palate (AEC) is a rare genetic disorder due to mutations in the TP63 gene.
|
19676058 |
2009 |
Ankyloblepharon
|
0.200 |
GeneticVariation
|
disease |
BEFREE |
Dominant mutations in TP63 cause ankyloblepharon ectodermal dysplasia and clefting (AEC), an ectodermal dysplasia characterized by skin fragility.
|
19681108 |
2009 |
Ankyloblepharon
|
0.200 |
GeneticVariation
|
disease |
BEFREE |
Moreover, we show that transcription of Dlx3 is abrogated by mutations in the sterile alpha-motif (SAM) domain of p63 that are associated with ankyloblepharon-ectodermal dysplasia-clefting (AEC) dysplasias, but not by mutations found in ectrodactylyectodermal dysplasia-cleft lip/palate (EEC), Limb-mammary syndrome (LMS) and split hand-foot malformation (SHFM) dysplasias.
|
17164413 |
2007 |
Ankyloblepharon
|
0.200 |
GeneticVariation
|
disease |
BEFREE |
Two novel TP63 mutations associated with the ankyloblepharon, ectodermal defects, and cleft lip and palate syndrome: a skin fragility phenotype.
|
16365259 |
2005 |
Ankyloblepharon
|
0.200 |
GeneticVariation
|
disease |
BEFREE |
However, p63 mutations associated with the ankyloblepharon-ectodermal dysplasia-clefting (AEC) syndrome (Hay-Wells syndrome) were found in the p63 carboxyl-terminal region with a sterile alpha-motif.
|
12692135 |
2003 |
Ankyloblepharon
|
0.200 |
GeneticVariation
|
disease |
BEFREE |
Several ectodermal dysplasia syndromes, including Ectrodactyly-Ectodermal dysplasia-Clefting (EEC) and Ankyloblepharon-Ectodermal Dysplasia-Clefting (AEC) syndromes, are known to result from mutations in the p63 gene.
|
12766194 |
2003 |
Ankyloblepharon
|
0.200 |
GeneticVariation
|
disease |
BEFREE |
A novel p63 sterile alpha motif (SAM) domain mutation in a Japanese patient with ankyloblepharon, ectodermal defects and cleft lip and palate (AEC) syndrome without ankyloblepharon.
|
12932250 |
2003 |
Ankyloblepharon
|
0.200 |
Biomarker
|
disease |
HPO |
|
|
|